Association of gastric fluid microbes at birth with severe bronchopulmonary dysplasia

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 94, Issue 1, 2009, Pages

  Oue, S ^a   Hiroi, M ^a   Ogawa, S ^a   Hira, S ^a   Hasegawa, M ^a   Yamaoka, S ^a   Yasui, M ^a   Tamai, H ^a   Ogihara, T ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INDOMETACIN; KL 6 PROTEIN; RNA 16S; UNCLASSIFIED DRUG; UREASE;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BIRTH; CHORIOAMNIONITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC ANALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; INTRAUTERINE INFECTION; LUNG DYSPLASIA; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; MICROBIAL IDENTIFICATION; MICROORGANISM; NEWBORN; NEWBORN INTENSIVE CARE; NONHUMAN; OUTCOME ASSESSMENT; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PERINATAL PERIOD; POLYMERASE CHAIN REACTION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH JUICE; TRACHEAL ASPIRATION PROCEDURE; UREAPLASMA;

EID: 58349092751     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2008.138321     Document Type: Article

References (34)

1. Fujimura M, Takeuchi T, Kitajima H, et al. Chorioamnionitis and serum IgM in Wilson-Mikity syndrome. Arch Dis Child 1989; 64:1379-83.
2. Watterberg KL, Demers L, Scott SM, et al. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97:210-15.
3. Lyon A. Chronic lung disease of prematurity. The role of intra-uterine infection. Eur J Pediatr 2000; 159:798-802.
4. Yoon BH, Romero R, Jun JK, et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8] and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997; 177:825-30.
5. Jobe AH, Ikegami M. Antenatal infection/inflammation and postnatal lung maturation and injury. Respir Res 2001; 2:27-32.
6. Speer CP. Inflammation and bronchopulmonary dysplasia; A continuing story. Semin Fetal Neonatal Med 2006; 11:354-62.
7. Cassell GH, Waites KB, Watson HL, et al. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns. Clin Microbiol Rev 1993, 6:69-87.
8. Waites KB, Katz B, Schelonka RL. Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev 2005; 18:757-89.
9. Wang EE, Frayha H, Watts J, et al. Role of Ureaplasma urealyticum and other pathogens in the development of chronic lung disease of prematurity. Pediatr Infect Dis J 1988; 7:547-51.
10. Cassell GH, Waites KB, Crouse DT, et al. Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in verylow-birth-weight infants. Lancet 1988; 2:240-5.
11. Sanchez PJ, Regan JA. Ureaplasma urealyticum colonization and chronic lung disease in low birth weight infants. Pediatr Infect Dis J 1988; 7:542-6.
12. Kafetzis DA, Skevaki CL, Skouteri V, et al. Maternal genital colonization with Ureaplasma urealyticum promotes preterm delivery: association of the respiratory colonization of premature infants with chronic lung disease and increased mortality. Clin Infect Dis 2004; 39:1113-22.
13. Colaizy TT, Morris CD, Lapidus J, et al. Detection of ureaplasma DI\IA in endotracheal samples is associated with bronchopulmonary dysplasia after adjustment for multiple risk factors. Pediatr Res 2007; 61:578-83.
14. Yoder BA, Coalson JJ, Winter VT, et al. Effects of antenatal colonization with Ureaplasma urealyticum on pulmonary disease in the immature baboon. Pediatr Res 2003; 54:797-807.
15. Viscardi RM, Atamas SP, Luzina IG, et al. Antenatal Ureaplasma urealyticum respiratory tract infection stimulates proinflammatory, profibrotic responses in the preterm baboon lung. Pediatr Res 2006; 60:141-6.
16. Groneck P, Goetze-Speer B, Speer CP. Inflammatory bronchopulmonary response of preterm infants with microbial colonization of the airways at birth. Arch Dis Child Fetal Neonatal Ed 1996; 74:F51-5.
17. Cordero L, Ayers LW, Davis K. Neonatal airway colonization with gram-negative bacilli: association with severity of bronchopulmonary dysplasia. Pediatr Infect Dis J 1997; 16:18-23.
18. Groneck P, Schmale J, Soditt V, et al. Bronchoalveolar inflammation following airway infection in preterm infants with chronic lung disease. Pediatr Pulmonol 2001; 31:331-8.
19. Miralles R, Hodge R, McParland PC, et al. Relationship between antenatal inflammation and antenatal infection identified by detection of microbial genes by polymerase chain reaction. Pediatr Res 2005; 57:570-7.
20. Weisburg WG, Barns SM, Pelletier DA, et al. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 1991; 173:697-703.
21. Greisen K, Loeffelholz M, Purohit A, et al. PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid. J Clin Microbiol 1994; 32:335-51.
22. Kotecha S, Hodge R, Schaber JA, et al. Pulmonary Ureaplasma urealyticum is associated with the development of acute lung inflammation and chronic lung disease in preterm infants. Pediatr Res 2004; 55:61-8.
23. Steel JH, Malatos S, Kennea N, et al. Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor. Pediatr Res 2005; 57:404-11.
24. Kohno N. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis. J Med Invest 1999; 46:151-8.
25. Ishizaka A, Matsuda T, Albertine KH, et al. Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2004; 286:L1088-94.
26. Al-Salmi QA, Walter JN, Colasurdo GN, et al. Serum KL-6 and surfactant protein A and D in pediatric interstitial lung disease. Chest 2005; 127:403-7.
27. Ogihara T, Hirano K, Morinobu T, et al. KL-6, a mucinous glycoprotein, as an indicator of chronic lung disease of the newborn. J Pediatr 2000; 137:280-2.
28. Ogihara T, Hirano K, Morinobu T, et al. Plasma KL-6 predicts the development and outcome of bronchopulmonary dysplasia. Pediatr Res 2006; 60:613-15.
29. Jobs AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163:1723-9.
30. Blanc WA. Amniotic infection syndrome: pathogenesis, morphology and significance in circumnatal mortality. Clin Obstet Gynecol 1959; 2:705-34.
31. ACOG Committee on Practice Bulletins-Obstetrics. AC0G Practice Bulletin No 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 2007; 109:1007-19.
32. Groneck P, Götze-Speer 8, Oppermann M, et al. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1994, 93:712-18.
33. Blanchard A. Hentschel J, Duffy L, et al. Detection of Ureaplasma urealyticum by polymerase chain reaction in the urogenital tract of adults, in amniotic fluid, and in the respiratory tract of newborns. Clin Infect Dis 1993; 17:S148-53.
34. Domingues D, Tavira LT, Duarte A, et al. Ureaplasma urealyticum biovar determination in women attending a family planning clinic in Guiné-Bissaù, using polymerase chain reaction of the multiple-banded antigen gene. J Clin Lab Anal 2002; 16:71-5.